Snellgrove Darren
SEC insider (Form 3/4/5 filer). CIK 0002137401. SVP, Chief Financial Officer at HALOZYME THERAPEUTICS, INC. (HALO). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in SAN DIEGO, CA.
Companies Snellgrove Darren has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Officer, SVP, Chief Financial Officer
Snellgrove Darren
CIK: 0002137401
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HALO
HALOZYME THERAPEUTICS, INC.
Officer